Inhibrx Biosciences, Inc.INBXNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
10.97%
↑ 125% vs avg
Percentile
P74
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-43.81%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 10.97% |
| Q3 2025 | -12.96% |
| Q2 2025 | 16.60% |
| Q1 2025 | 17.88% |
| Q4 2024 | -43.27% |
| Q3 2024 | 47.88% |
| Q2 2024 | 8.72% |
| Q1 2024 | -6.48% |
| Q4 2023 | -9.46% |
| Q3 2023 | -29.19% |
| Q2 2023 | -6.63% |
| Q1 2023 | -29.48% |
| Q4 2022 | -0.16% |
| Q3 2022 | -13.12% |
| Q2 2022 | -0.69% |
| Q1 2022 | -18.22% |
| Q4 2021 | -65.32% |
| Q3 2021 | 39.26% |
| Q2 2021 | -5.23% |
| Q1 2021 | -35.38% |
| Q4 2020 | -12.83% |
| Q3 2020 | -21.51% |
| Q2 2020 | -56.05% |
| Q1 2020 | 39.08% |
| Q4 2019 | -727.29% |
| Q3 2019 | 89.75% |
| Q2 2019 | -156.00% |
| Q1 2019 | 24.83% |
| Q4 2018 | 0.00% |
| Q2 2018 | -517.54% |
| Q1 2018 | 69.76% |
| Q4 2017 | 0.00% |